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Open access undeAbstract: Despite the advances in cancer medicine and the resultant 20% decline in cancer death
rates for Americans since 1991, there remain distinct cancer health disparities among African
Americans, Hispanics, Native Americans, and the those living in poverty. Minorities and the poor
continue to bear the disproportionate burden of cancer, especially in terms of stage at diagnosis,
incidence, and mortality. Cancer health disparities are persistent reminders that state-of-the-art
cancer prevention, diagnosis, and treatment are not equally effective for and accessible to all
Americans.
The cancer prevention model must take into account the phenotype of accelerated aging
associated with health disparities as well as the important interplay of biological and sociocultural
factors that lead to disparate health outcomes. The building blocks of this prevention model will
include interdisciplinary prevention modalities that encourage partnerships across medical and
nonmedical entities, community-based participatory research, development of ethnically and
racially diverse research cohorts, and full actualization of the prevention beneﬁts outlined in the
2010 Patient Protection and Affordable Care Act. However, the most essential facet should be a
thoughtful integration of cancer prevention and screening into prevention, screening, and disease
management activities for hypertension and diabetes mellitus because these chronic medical
illnesses have a substantial prevalence in populations at risk for cancer disparities and cause
considerable comorbidity and likely complicate effective treatment and contribute to dispropor-
tionate cancer death rates.
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MedicineHealth DisparitiesHealth disparities are differences in the incidence,prevalence, mortality, and burden of diseaseand other adverse health conditions among
speciﬁc groups in the U.S. These groups may be based
on race or ethnicity, gender, education, SES, or other
criteria. Health disparities among ethnic minorities, the
poor, and the medically underserved are well docu-
mented. There are disparities for overall longevity
measured by life expectancy and for speciﬁc chronic
and acute diseases.
Despite improving life expectancy and declines in
death rates, there are considerable and persistent
disparities for minorities. Life-expectancy data show a
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r CC BY-NC-ND license.2011 with evidence of a consistent narrowing.1 Murray
and colleagues examined mortality disparities in eight
subgroups of the U.S. population, revealing signiﬁcant
disparities in mortality.2 This was most pronounced for
African-American men, who experienced a 20.7-year life
expectancy gap, compared to Asian women, who had the
best overall survival. Among men, there was a 15.4-year
survival gap between the best-off Asian American men
and African-American men residing in high-risk urban
areas. There was a 12.8-year survival gap between Asian
American women and low-income southern rural
African-American women. This study also documented
that the disparities in mortality was largest among young
(ages 15–44 years) and middle-age (ages 45–64 years)
African Americans. The causes of this excess mortality
included injuries, cardiovascular disease, diabetes melli-
tus, and other noncommunicable diseases.2
The causes of excess mortality for young and middle-
aged African Americans are also sources of disparate
disease burden and death among other American minor-
ities. Native Hawaiians/Paciﬁc Islanders and Hispanic
adults are diagnosed with diabetes at rates three times
and 1.7 times higher than non-Hispanic whites. Americane Medicine Am J Prev Med 2014;46(3S1):S87–S97 S87
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disease at rates twice that of non-Hispanic whites. In
association with chronic medical illness, 14.4% of non-
Hispanic blacks are disproportionately severely disabled
compared to non-Hispanic whites (12.4%); Hispanics
(8.7%); and Asians (7.6%).3
The cause of health disparities clearly involves the
conjoined inﬂuences of the environment, behavior,
sociocultural factors, and biology (the genome and
epigenome) on individuals from birth (Figure 1). The
dysfunctional interaction of these factors ultimately
results in the accelerated aging phenotype of health
disparities, which is characterized by the early appear-
ance of age-associated disease that in turn complicates
cancer diagnosis and treatment planning, ultimately
resulting in premature death and differential 5-year
survival. This disparate life span may be marked by early
cancer initiation, promotion, and transformation events
caused by low SES, environment, diet, exposures, or
biological factors that are part and parcel of the health
disparities phenotype.
Perhaps the most potent nonbiological factor inﬂuenc-
ing the development of health disparities is poverty.
Poverty conditions the environment as well as induces
some of the behavioral and sociocultural factors that are
present at birth and exerts profound inﬂuence over the
entire life course (Figure 1). Poverty sets the stage for low
educational and occupational achievement, unhealthy
behavioral habits, and poor housing, all of which directly
affect health, the differential development of chronic
diseases including cancer, and ultimately shorter life30 years
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Figure 1. Cancer prevention in a Health Disparities Frameworkexpectancy. Detrimental unhealthy behaviors like smok-
ing directly affect health disparities in general and cancer
health disparities speciﬁcally. The prevalence of tobacco
use is higher among low-SES groups, increasing the risk
of death and disability.4 Various studies have shown that
much of the differential death rate attributed to SES is
related to tobacco use.5 Although African Americans in
general may smoke less than non-Hispanic whites, the
SES differential in smoking, the prevalence of poverty,
and the greater susceptibility to smoking-induced cancer
among African Americans documented in some studies
inﬂuences cancer disparities, highlighting the importance
of behavior and its interaction with genotype as high-
lighted in Figure 1.6,7
With this background, a discussion of health dispar-
ities in the setting of cancer prevention raises a broad
spectrum of issues, including cancer health disparities
and how these disparities inﬂuence the success and
effectiveness of prevention efforts, speciﬁc relevant bar-
riers, and appropriate methods to negotiate these bar-
riers. To this end, this topic will be discussed in the
framework of speciﬁc cancer health disparities, cancer
prevention in populations at risk with a focus on system,
cultural, and community-based cancer prevention strat-
egies. Identifying and negotiating the barriers of effective
cancer prevention in the context of health literacy,
cultural competence, and mobile health technologies is
outlined. Finally, this article highlights the future gains
that may accrue from full implementation of the Afford-
able Care Act and enhancement of initiatives that focus
on integration of cancer prevention into ongoing healthDiabetes and hypertension-
linked cancer prevention
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disease.Cancer Health Disparities
There are considerable dispar-
ities in cancer incidence among
selected minority groups and
non-Hispanic whites. African-
American men have a 14%
higher incidence of cancer when
compared to white men; how-
ever, African-American women
have a lower cancer incidence
than white women. American
Indians/Alaska Natives, Asian/
Paciﬁc Islanders, and Hispanics
have overall incidence rates
lower than both whites and Afri-
can Americans. Age-adjusted
Surveillance, Epidemiology, and
End Results (SEER) incidencewww.ajpmonline.org
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African Americans; and 356.7, 323.6, and 307.4/100,000
for Hispanics, American Indians, and Asian/Paciﬁc
Islanders, respectively. Incidence rates for the most
frequently occurring cancers shows that in men prostate
cancer is the most common among all racial and ethnic
groups.8 African-American men have the highest inci-
dence at 96.3/100,000 compared with 66.1, 35.5, 34.3, and
55.2 for whites, Asian/Paciﬁc Islanders, American
Indian/Alaska Natives, and Hispanics, respectively. A
similar pattern of incidence is present for breast, lung and
bronchus, and colon and rectum cancers.9
As noted, cancer incidence rates are lower in selected
minority groups compared to whites, except that for
many cancers associated with infectious agents, the
reverse is the case. These cancers include the uterine
cervix, stomach, and liver. However, once acculturated
after living within the U.S. for extended periods, rates for
the four most common malignancies begin to increase
among these groups.10–12 However, it should be noted
that although the overall incidence of cancer in American
Indian/Alaska Natives is lower than non-Hispanic
whites, when incidence rates are examined geographi-
cally, there are signiﬁcant differences in incidence
between American Indians/Alaska natives and non-
Hispanic whites, especially in the Northern Plains and
Alaska.13,14 As mentioned earlier, race and ethnic herit-
age are not the only factors that inﬂuence cancer
incidence. There are widely described socioeconomic
determinates of cancer. Cancer incidence rates clearly
delineate that social inequality as well as SES is linked to
cancer in both ﬁrst and third world countries.15 The risk
of developing a number of cancers is higher the lower one
is on the socioeconomic ladder. These include colon,
bone melanoma, breast, ovarian, and cervical cancers.16
The differential risk of developing certain malignancies
is inﬂuenced not only by sociocultural factors but also by
obesity. In recent years, the evidence has convincingly
highlighted the role of obesity in cancer incidence as study
after study correlated obesity with incidence for several
cancer types, including colon, liver, breast, and kidney
among others.17 The role of diet and nutrition may be
particularly important factors in cancer risk among
vulnerable populations. Approximately 68% of American
adults are overweight or obese.18 Obesity rates vary
considerably among non-Hispanic whites and minority
subpopulations; for example, non-Hispanic black women
(49.6%) and Mexican-American women (45.1%) are
signiﬁcantly more likely to be obese than non-Hispanic
white women (33.0%). There are also differences in
obesity rates between men of different racial and ethnic
groups. These disparities in obesity contribute to differ-
ential incidence rates of cancer among minorities.March 2014Cancer death rates have declined in all population
groups amid the overall 20% cancer death rate decline
documented in the United Sates (24% in men and 16% in
women) between 1990/1991 and 2009.19 Annual declines
in the overall cancer death rate during 2000–2009 were
actually highest among African-American men (2.4%)
and Hispanic men (2.3%). The overall death rate decline
in non-Hispanic white men was 1.7%. The declines for
African-American and white women were similar (1.5%
vs 1.4%). There were also signiﬁcant declines for His-
panic women (1.4%) and Asian American/Paciﬁc
Islander men and women (1.5% and 1.1% decline,
respectively). However, there was no decline in death
rates among American Indians/Alaska Natives.
Despite this progress, death for all cancers combined
for the period 1975–2009 show a disparate proportion
among African Americans compared to non-Hispanic
whites. African-American men have a 33% higher death
rate when compared to white men whereas African-
American women have a 16% higher cancer death rate.
The largest disparities result from the substantially
higher death rates for cancer of breast and colorectum
in women and colorectal carcinoma, lung, and prostate
death rates in men.20 Death rates for all cancer sites
combined and the four most common cancer sites
combined are lower among other American racial/ethnic
groups (e.g., Hispanics) than those for African-American
and non-Hispanic whites. However, for cancers linked
with infectious agents (e.g., Helicobacter pylori, hepatitis
B virus, and human papillomavirus) there are higher
death rates in selected minority subgroups, including
Asian American/Paciﬁc Islanders and Hispanics,
when compared to non-Hispanic whites.19,21 African-
American 5-year survival rates are lower for almost every
cancer site.19 Although Hispanics have 5-year cancer-
speciﬁc survival rates similar to non-Hispanic whites for
most cancers, cancer mortality rates for Hispanics are
higher for cancers of the gallbladder, stomach, liver, and
bile duct.
As is the case with cancer incidence, the disparities in
cancer mortality are not solely related to race and
ethnicity; socioeconomic factors are inextricably inter-
twined as etiologic and disease promotion or progression
agents. Freeman and Chu consider the interaction of
social injustice, culture, and poverty as critical factors
that interfere with and impede effective cancer preven-
tion and early detection. Consequently, low SES and
perhaps race and ethnicity inﬂuence treatment and
survival rates.22 For example, the black–white disparities
in breast cancer mortality have been shown to be linked
to barriers of poverty (access to care, health insurance,
competing survival prioritization and others); medical
mistrust; as well as perceived racial prejudice.23
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which may account for some of the disproportionate
impact of speciﬁc cancers.24,25 For example, obesity
increases prostate-speciﬁc cancer mortality and is linked
with increase in aggressive prostate cancer pathology.26
Increased body weight may act as a promoter of
important factors that enhance progression.27 Several
studies have also shown that obesity is a major factor in
post-menopausal breast cancer and colorectal cancer
death rates, treatment efﬁcacy, and survival.
Cancer Prevention in At-Risk Populations
In the face of these differential incidence and mortality
rates, prevention and screening efforts to reverse these
trends have had varying degrees of success. Rates of
mammography screening have increased for women in
all racial and ethnic groups since the late 1980s.28 In
2008, among African-American women 40 and older,
approximately 67.7% reported undergoing mammo-
grams within the 2 years. In this same group, only
52.2% were tested in the past year despite then guidelines
recommending yearly testing and despite the fact that
African-American women frequently have deadlier
breast cancers at younger ages. Mammography use has
grown among non-Hispanic blacks (78.6%) but contin-
ues at low rates of mammography among American
Indian/Alaska Natives (63.9%); those with annual house-
hold income r$15,000 (63.2%); and those with no
health care (50.4%).29 Colorectal cancer screening rates
have increased tremendously among African-American
men and women since the late 1980s when both groups
were examined at extremely low rates (18% and 15%,
respectively).30 The 2008 National Health Interview
Survey documented increasing rates of colorectal cancer
screening for African Americans to 49% compared to
56% for non-Hispanic whites. The Behavioral Risk Factor
Surveillance System reported that non-Hispanic whites
and African Americans had comparable rates of color-
ectal cancer screening (66.3 and 65%, respectively).31
However, screening rates were substantially lower for
Hispanics and those with low educational attainment and
low SES.
System-Based Prevention Strategies
Persistent disparities suggests that a successful preven-
tion strategy must include myriad other prevention and
early treatment strategies that are culturally appropriate
and targeted to the unique aspects of the populations at
greatest risk for disease development. In populations
with ongoing major health disparities, screening is the
key to decreasing the proportion of advanced stage at
diagnosis cases. Farley and colleagues32 have noted thatonly a small increase in mammography use, perhaps 5%,
could prevent approximately 500 breast cancer deaths
each year. RCTs have established valid and efﬁcacious
strategies, many of which emphasize participation in
cancer screening by using culturally and linguistically
appropriate messages as well as trained culturally reliable
messengers. For example, Ayudando a las Mujeres con
Informacion, Guida, y Amor para su Salud (AMIGAS,
“helping women with information, guidance, and love for
their health”) is an RCT examining the effectiveness of
trained lay health workers (promotoras) in improving
Pap test screening among three populations of women
from Mexico.33 The intervention increased Pap test
screening in Mexican women residing in three different
types of residential areas. Other RCTs also focused on
increasing breast and cervical cancer screening in diverse
groups of African-American, Latina, Asian, Arab, and
rural women using community-based participatory
research (CBPR), faith-placed research intervention,
patient navigators, and lay health workers with variably
packaged educational modules.34–39Community and Culturally Based Prevention
Strategies
Cancer prevention efforts using community members to
help design and implement those efforts appear to be
closing the screening gap between non-Hispanic whites
and other groups. Additionally, community outreach
through coalitions and churches are promising despite
needing further evaluation.40,41 These efforts combine
the beneﬁts and talents and training of professional and
lay workers to make accessible all cancer prevention
resources to as many vulnerable populations as possible.
One of the best examples of using community
resources is the use of community members and/or
paraprofessionals, broadly deﬁned as community health
workers or lay health advisors.42,43 These laypersons
work in paid or volunteer positions. They provide health
education and health promotion activities in a culturally
and linguistically competent manner as members of the
community who share language or racial/ethnic heritage
with the community they serve. Whether they are called
community health workers, lay health advisors, peer
health educators or promotores, they provide valuable
resources for community-based research as well as cancer
prevention and screening activities. Several studies have
examined how using community health workers
improves cancer education and cancer screening rates
among Latinas, Appalachian women, African-American
women, and other minority groups.42,44–47 The literature
also suggests that the community health workers were
underutilized because the scope of their roles was narrow.www.ajpmonline.org
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their roles may provide the cross-community linkage
needed to address racial/ethnic disparities in cancer.43
The use of CBPR is important to highlight in this
setting. Implementing research that respects the com-
munity and its institutions is among the best methods for
enhancing community awareness of cancer prevention.
This method also increases minority participation in
cancer prevention trials, which may also yield permanent
changes in health behaviors among populations at
increased risk. An excellent example of this approach is
the work done by the Center for Interdisciplinary Health
Disparities Research in exploring the differences in breast
cancer mortality among African Americans and whites in
Chicago.48Challenges and Evidence-Based Solutions to
Improve Minority Representation
Future RCT and CBPR studies should validate these
models in larger cohorts, especially among minority men
who are most at risk and are the most difﬁcult to recruit.
They should also examine cost effectiveness, evaluate the
mechanisms through which these effective interventions
achieve improved compliance with screening, and most
importantly propel implementation of the methodology
into clinical practice settings.
Although some randomized clinical trials in cancer
prevention research have focused repeatedly and specif-
ically on minority populations, consistent inclusion of
vulnerable populations has been more limited. Just as
minorities are frequently underrepresented in cancer
treatment trials, they remain appreciably underrepre-
sented in cancer prevention studies.49 Although well
funded as a randomized trial to evaluate the effectiveness
of screening, the Prostate, Colorectal, Lung and Ovarian
(PLCO) screening trial failed to recruit African Ameri-
cans, Hispanics, or Asians in proportions that were
representative of age-eligible individuals in the overall
U.S. population or in their catchment areas. Of the
155,000 participants, 5% were African American, 1%
were Hispanics, and 3.6% were Asian.50 The considerable
challenge of recruiting minority population into chemo-
prevention trials requires an ongoing iterative examina-
tion that pinpoints the barriers to participation for
different studies.
The Centers for Population Health and Health Dis-
parities (CPHHD) initiative identiﬁed several factors that
inﬂuence minority recruitment and retention, including
use of multiple recruitment sites, culturally appropriate
invitations, ﬂexible study designs, and perhaps most
importantly the ability to modify recruitment strategies
during the course of the study.51 Aware of the criticalMarch 2014need to recruit minority women into the Study of
Tamoxifen and Raloxifene (STAR) trial, the National
Surgical Adjuvant Breast and Bowel Projects (NSABP)
Breast Cancer Prevention Trial (BCPT) used real-time
assessments to evaluate success and failure of recruitment
efforts.52 STAR investigators did not wait until the study
was completed to assess inconsistencies between the
actual recruitment and the predicted eligible percentage
of the population. The investigators monitored recruit-
ment among minority women. This allowed them to
identify and negotiate the barriers to participation and
make important operational changes to improve recruit-
ment of targeted populations while the study was still
ongoing. This active and iterative approach improved
minority accrual rates in NSABP’s previous Breast
Cancer Prevention Trial from 3.5% to 6.5% in STAR.
It is likely that these intensiﬁed efforts increase the cost
of research studies. If the goal is to improve recruitment
and retention, the excess cost may be justiﬁed if the
strategies employed are effective. Other studies not only
track this specialized recruitment success in real time but
also assess the cost effectiveness of each modality
employed so that they can more accurately target limited
research dollars for maximal recruitment beneﬁt.53 Our
own work in developing an observational longitudinal
study on the inﬂuence of race and SES on the development
of age-associated health disparities among middle-aged
residents of Baltimore outlines important barriers that are
as relevant and applicable in observational clinical
research as in cancer prevention research.54 Three broad
areas of barriers were identiﬁed that operate in close
contiguity: individual-based barriers, community-based
barriers, and researcher-based barriers. Individual barriers
include medical mistrust, low literacy, low health literacy,
economic constraints, multiple comorbidities, behavioral
and social issues, and transportation among others. There
are also community-based barriers that include safety,
neighborhood health literacy, education, and fear of
exploitation. Finally, there are perhaps the most difﬁcult
to address barriers: those presented by researchers them-
selves, including personal biases and lack of community
membership and community perspective.Negotiating the Barriers to Effective Cancer
Prevention
Health Literacy and Cancer Prevention
Health literacy is “the degree to which individuals can
obtain, process, and understand the basic information and
services they need tomake appropriate health decisions.”55
In 2004, the IOM estimated that almost 90 million U.S.
adults had low levels of health literacy.56Work by multiple
Zonderman et al / Am J Prev Med 2014;46(3S1):S87–S97S92groups has linked health disparities and multiple chronic
illnesses or comorbid conditions to low levels of liter-
acy.57–60 Reading and numerical skills are required to
function effectively in healthcare environments. Low levels
of health literacy are independent risk factors for unto-
ward health outcomes, including re-hospitalization for
heart failure.61,62 Those with low educational attainment
have more difﬁculty processing the relevance of and
adhering to medical prescriptions.63,64
Just as health literacy is a focal point in health disparities
research, it is also a focal point of cancer prevention efforts
especially among young adults, who might beneﬁt most
from effective cancer prevention efforts. The barriers for
effective cancer screening include patients’ abilities to
understand the beneﬁts of screening procedures, mistrust
of healthcare providers, differences in knowledge between
the provider and patients, and the inability of providers to
bridge this knowledge gap by adequately addressing the
expressed concerns. These factors are among those that
have driven the inequality of effective and consistent cancer
prevention in minority populations.65–67 The complexities
of cancer and the nuances increasingly associated with
screening guidelines lead to confusion among well-
educated high-SES populations, particularly when guide-
lines change over time.68 Individuals with low educational
attainment often have difﬁculty navigating cancer screen-
ing recommendations, which are complex. Only 50% of
low-literacy patients referred for colorectal screening
completed the test.69 Those with low literacy are consid-
erably less likely to participate in routine cancer screening
and prevention.70,71Cultural Competency and Doctor–Patient
Communication
Failure to understand the principles of cultural compe-
tence and modify care patterns accordingly has substan-
tially detrimental effects on health outcomes for
individuals and for communities.72 Providers are respon-
sible for developing culturally competent relationships
with patients; the quality of these relationships has direct
bearing on health outcomes. There is a discrepancy in the
provider–patient relationship such that physicians build
productive relationships with more educated and afﬂuent
non-Hispanic whites, whom they may view as more like
themselves. This discrepancy results in stereotyping
and bias.73 Healthy relationships between healthcare
providers and patients improve communication and
build trust.65 Understanding individuals’ and commun-
ities’ cultural contexts are equally important or perhaps
even more important for clinical investigators. Research-
related clinical competence is recognizing and responding
appropriately to key cultural features that affect clinicalresearch or clinical care.74 In cancer prevention, cultural
competence is particularly crucial because highly
emotional discussions about cancer may have cultural
overtones and stigma associated with potential
diagnoses.75
The role of providers in improving adherence to
cancer screening is undeniable. A physician can inﬂuence
a patient’s decision to undergo cancer screening.76
Cancer prevention research and interventions should
focus on the provider’s acculturation and linguistic
appropriateness as well as training the provider to use
communication methods and skills that will enhance
their relationships with their patients.77 RCT studies
should examine the best ways to dispel individual fears
and mistrust among patients, gain true informed consent
for screening procedures, and provide information from
sources relevant to minorities, the poor, and people with
low educational attainment.Mental Health Challenges in At-Risk
Populations
There are considerable challenges in cancer screening,
prevention, and treatment among individuals with poor or
dysfunctional mental health.78,79 These challenges are
exacerbated among those who are members of minority
ethnic and racial groups.80 There is only sparse literature
about these issues for those whose vulnerabilities are
ampliﬁed by their dual status as members of minority
groups with mental illnesses. There are substantial health
disparities associated with psychiatric disorders such that
those with mental illnesses have greater numbers of more
severe comorbid somatic conditions than those without
psychiatric conditions.81 In addition, cancer screening is
much less common among those with psychiatric illnesses.
However, there are no studies on the modifying effects of
racial status or SES on the association of depressive
symptoms with cancer screening participation. Despite
lower mammography rates in underserved populations,
there is no evidence that mental illnesses are associated
with mammography screening rates in a primary care
setting.82The Challenge of Multiple Comorbidity
The overall health status of Americans in general has
changed with the aging of the population and the
emerging prevalence of obesity and type 2 diabetes
mellitus in younger age groups. The National Center
for Health Statistics data show that over the past 10 years
there is increasing prevalence of two or more chronic
conditions among adults aged 45–64 years and among
adults aged Z65 years. This increase in prevalence is
present in men and women as well as among all racialwww.ajpmonline.org
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adults aged 45–64 years have two or more chronic
medical conditions. For populations at risk for health
disparities, non-Hispanic black adults had a higher
prevalence of two or more chronic conditions when
compared to non-Hispanic whites.
Those living in poverty had a prevalence twice that of
those living at or above 400% of the poverty level. The co-
occurrence of hypertension and diabetes mellitus occurs in
approximately 2.4% among non-Hispanic white adults.84
However, the percentage is greater than or equal to double
that among African-American (6.1%) andMexican Amer-
ican adults (4.9%). The presence of multiple chronic
conditions adds a considerable level of complexity to the
development and implementation of efﬁcacious cancer
prevention strategies. In fact, the rates of comorbidity in
the U.S. population overall present a major challenge to
healthcare delivery in general.85 As Parekh and Barton call
for increased care coordination and realization that
modern medicine has created disease “silos” that focus
on one chronic condition instead of the comorbidity
complex, cancer prevention practitioners must confront
these same issues and ﬁnd ways to interdigitate prevention
into ongoing care of comorbid illnesses.
Tools for Cancer Prevention Research
Mobile Health Technologies
Although there is a digital divide in computer ownership
and home Internet access based on geographic location
within the U.S. (urban versus rural), age, income, and
education, there is clear evidence that the Internet is
widely available to populations at risk for disparity.
African Americans, other minorities, and low-SES pop-
ulations may have less access to home-based high-speed
broadband but they may compensate by using public
sites such as community libraries or by using Internet-
enabled mobile phones. More than 80% of the world has
access to cell phones.86 The penetrance of cell phones is
so deep that in U.S. cities, almost 50% of the homeless
have access to cell phones. Currently 83% of U.S. adults
own a cell phone; 47% of African Americans and 49% of
Hispanics own smartphones compared with 42% of non-
Hispanic whites according to the Pew Research Center.
Approximately 25% of those with smartphones use them
as a primary source of Internet access. Among cell phone
users, 73% use text messaging; however, text messaging
utilization is much higher among African Americans and
Hispanics compared to non-Hispanic whites. Studies
among young, urban African Americans, rural whites,
and Hispanic women demonstrated interest in receiving
information about health issues (including breast cancer)
via text messaging or cell phone.87–89 Data on technologyMarch 2014adoption by minority populations suggest that this
avenue must be pursued to eliminate cancer health
disparities.The Affordable Care Act
The Patient Protection and Affordable Care Act (ACA)
provides insurance reform, improved access to care, and
improved quality of care. Importantly, it implements
initiatives to eliminate health disparities. The ACA
requires collecting self-report data particularly relevant
to cancer health disparities on race, ethnicity, gender,
disability status, and language. The ACA has cancer-
speciﬁc measures that affect cancer care delivery and
cancer prevention. The law addresses mandatory cover-
age of prevention services including smoking cessation,
weight loss, and promotion of healthy behaviors in
addition to cancer screening. ACA provisions such as
the essential health beneﬁts package, state healthcare
workforce development grants, and other parts of the law
will potentially eliminate barriers to preventive health
screenings that are essential in achieving lower cancer
death rates among those at highest risk.
Clinical preventive services denoted as Grade A or B
by the U.S. Preventive Services Task Force (USPSTF) are
covered by the ACA, easing access to care and lowering
out-of-pocket expenses. This is especially important
given that lack of insurance and low income are two
important barriers identiﬁed for both breast and color-
ectal screening among women and minorities.29,31 The
challenge for the cancer prevention community is to
remain a vital voice in the implementation phase of ACA
and to highlight inadequacies as the basis for future
amendments or revisions of speciﬁc provisions. For
example, Moy and colleagues90 point out that USPSTF
cancer screening recommendations are based on data
from non-Hispanic whites not minorities because to date
there is little data about optimal screening in minority
populations for malignancies with disparate impact on
minority populations. This is an area for further research
by cancer prevention specialists.Integration of Cancer Prevention Into Ongoing
Health Promotion Initiatives
Our view of cancer health disparities must be considered
in the context of overall health disparities. The leading
cause of death for all Americans remains cardiovascular
disease; however, cancer is the leading cause of death for
those aged 45–64 years, with cardiovascular disease a
relatively distant third.91 Consequently, combining can-
cer prevention with efforts to control blood pressure and
reduce salt intake might have an additive effect on the
reduction in health disparities overall given the very high
Zonderman et al / Am J Prev Med 2014;46(3S1):S87–S97S94rate of stroke and cardiovascular morbidity and mortality
experienced by African Americans in middle age.
Fusing cancer prevention efforts with cardiovascular
disease risk factor screening is not a new idea. In 1993,
Congress authorized WISEWOMAN (Well-Integrated
Screening and Evaluation for Women across the Nation)
to provide preventive health services to women who had
already participated in another screening initiative, the
National Breast and Cervical Cancer Early Detection
Program (NBCCEDP).92 The goal of WISEWOMAN is
to reach out to low-income, uninsured women (ages 40–64
years) to control cardiovascular risk factors and improve
cardiovascular health. Women in this study receive screen-
ing for breast and cervical cancer along with the cardio-
vascular screening at the same appointment. The value of
WISEWOMAN is that it successfully reaches at-risk
women and addresses screening and health promotion
in both cancer and cardiovascular disease simultaneously.Cancer Prevention and Education
The link between educational attainment and health
outcomes cannot be overstated. The clearest evidence that
education must be a high priority in the U.S. comes from
Olshansky and colleagues’ recent work highlighting the
direct connection between education and life expectancy
among minorities as well as non-Hispanic whites.93
Analyses of life expectancy in 2008 revealed the presence
of two Americas demarcated by level of education and
race. Those with less than 12 years of education had life
expectancies comparable to those in the middle of the 20th
century. Differences in education produced expected gaps
between African Americans and non-Hispanic whites in
life expectancy (white men with greater than 16 years of
education enjoyed 14.2 additional years of life expectancy
than African-American men). The least educated in
American society are experiencing a contraction in life
expectancy, making it crucial for us to be concerned about
American education policy.
The magnitude of the inﬂuence of educational attain-
ment on health and health disparities is enormous. Low
levels of educational attainment directly contribute to
low health and science literacy, which in turn become
high barriers to effective cancer prevention and health
promotion. Early intervention is crucial to prevent cancer
in the high-risk ages 45–64 years to effectively address
cancer health disparities and intercept events that initiate
and promote cancer, which happen earlier in populations
at risk as outlined in Figure 1. Health professionals must
begin to formally and consistently partner with and
advocate for educational partners. Advocating for
improvement to the American educational system with
special focus on schools in poor and minoritycommunities may be one of the most effective cancer
prevention strategies to overcome the barriers that
impede swift reduction in cancer health disparities.
Conclusion
There are numerous gaps in our knowledge about the
speciﬁc molecular mechanisms through which social
determinants of health are transduced into differential
cancer outcomes. Some of the relevant factors lie outside of
the direct scope of healthcare researchers and providers but
within the realm of political will and governmental action
to address the roots of poverty in our society. However,
within the realm of the health professional, it is possible to
design, develop, and implement novel approaches that
address cancer health disparities at the prevention level that
override the traditional medical specialty–speciﬁc “silo”
approach, incorporate technology, enhance health literacy
and patient health education, and negotiate barriers
associated with poverty, language, and culture.
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